These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33257042)

  • 1. Protective Effects of Anti-depressants against the Subsequent Development of Psoriasis in Patients with Major Depressive Disorder: a Cohort Study.
    Tzeng YM; Li IH; Kao HH; Shih JH; Yeh CB; Chen YH; Kao LT
    J Affect Disord; 2021 Feb; 281():590-596. PubMed ID: 33257042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major depressive disorder is associated with subsequent adult-onset asthma: a population-based cohort study.
    Shen TC; Lin CL; Liao CH; Wei CC; Sung FC; Kao CH
    Epidemiol Psychiatr Sci; 2017 Dec; 26(6):664-671. PubMed ID: 27641623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major depressive disorder increased risk of psoriasis: A propensity score matched cohort study.
    Chen YH; Wang WM; Li IH; Kao HH; Yeh CB; Kao LT
    J Affect Disord; 2021 Jan; 278():407-412. PubMed ID: 33010565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of sedative-hypnotics in patients with recurrent major depressive disorder: a nationwide population-based 14-year follow-up study in Taiwan.
    Chung KH; Lee TY; Chung MH
    Psychopharmacology (Berl); 2021 Jun; 238(6):1553-1561. PubMed ID: 33630108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fluoxetine: an update of its use in major depressive disorder in adults].
    Gourion D; Perrin E; Quintin P
    Encephale; 2004; 30(4):392-9. PubMed ID: 15597466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressants Reduced Risk of Mortality in Patients With Diabetes Mellitus: A Population-Based Cohort Study in Taiwan.
    Chen HM; Yang YH; Chen KJ; Lee Y; McIntyre RS; Lu ML; Lee YC; Hsieh MC; Chen VC
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4619-4625. PubMed ID: 31265070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAs.
    Doyle JJ; Casciano J; Arikian S; Tarride JE; Gonzalez MA; Casciano R
    Value Health; 2001; 4(1):16-31. PubMed ID: 11704969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorder.
    Papakostas GI; Homberger CH; Fava M
    J Psychopharmacol; 2008 Nov; 22(8):843-8. PubMed ID: 18308801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between major depressive disorder and subsequent autoimmune skin diseases: A nationwide population-based cohort study.
    Dai YX; Tai YH; Chang YT; Chen TJ; Chen MH
    J Affect Disord; 2020 Sep; 274():334-338. PubMed ID: 32469824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
    Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
    Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of selective serotonin reuptake inhibitors versus tricyclic antidepressants on cerebrovascular events: a nationwide population-based cohort study.
    Lee YC; Lin CH; Lin MS; Lin JW; Chang CH; Lai MS
    J Clin Psychopharmacol; 2013 Dec; 33(6):782-9. PubMed ID: 24091857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic impact of therapeutic substitution of a brand selective serotonin reuptake inhibitor with an alternative generic selective serotonin reuptake inhibitor in patients with major depressive disorder.
    Wu EQ; Yu AP; Lauzon V; Ramakrishnan K; Marynchenko M; Ben-Hamadi R; Blum S; Erder MH
    Ann Pharmacother; 2011 Apr; 45(4):441-51. PubMed ID: 21415162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder.
    Oakes TM; Dellva MA; Waterman K; Greenbaum M; Poppe C; Goldberger C; Ahl J; Perahia DG
    Curr Med Res Opin; 2015 Jun; 31(6):1179-89. PubMed ID: 25894953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents.
    Papakostas GI; Thase ME; Fava M; Nelson JC; Shelton RC
    Biol Psychiatry; 2007 Dec; 62(11):1217-27. PubMed ID: 17588546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of major depressive disorder among probands with psoriasis and unaffected siblings: a nationwide population-based study.
    Dai YX; Chen CC; Tai YH; Chang YT; Chen TJ; Chen MH
    J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):1510-1515. PubMed ID: 31989673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks of suicide and poisoning among elderly patients prescribed selective serotonin reuptake inhibitors: a retrospective cohort study.
    Rahme E; Dasgupta K; Turecki G; Nedjar H; Galbaud du Fort G
    J Clin Psychiatry; 2008 Mar; 69(3):349-57. PubMed ID: 18278986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tonsillectomy and the subsequent risk of psoriasis: A nationwide population-based cohort study.
    Chen ML; Ku YH; Yip HT; Wei JC
    J Am Acad Dermatol; 2021 Dec; 85(6):1493-1502. PubMed ID: 33548305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective Serotonin Reuptake Inhibitor Use and Risk of Arrhythmia: A Nationwide, Population-Based Cohort Study.
    Lin YT; Lu TS; Hansen RA; Wang CC
    Clin Ther; 2019 Jun; 41(6):1128-1138.e8. PubMed ID: 31178037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study.
    Valuck RJ; Libby AM; Sills MR; Giese AA; Allen RR
    CNS Drugs; 2004; 18(15):1119-32. PubMed ID: 15581382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant medication exposure and 5-HT
    Metts AV; Rubin-Falcone H; Ogden RT; Lin X; Wilner DE; Burke AK; Sublette ME; Oquendo MA; Miller JM; Mann JJ
    Synapse; 2019 Jun; 73(6):e22089. PubMed ID: 30693567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.